Merck to acquire US biotech company Pandion Therapeutics for $1.8bn

Merck has agreed to acquire Pandion Therapeutics, a Massachusetts-based clinical-stage biotech company, for about $1.85 billion in an all-cash deal. Pandion Therapeutics is engaged in ... Read More